Literature DB >> 728149

A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.

J E Greenwald, L K Wong, M Rao, J R Bianchine, R V Panganamala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 728149     DOI： 10.1016/0006-291x(78)91698-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  6 in total

1.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

2.  Effect of dipyridamole on the formation of 6-oxo-prostaglandin F1 alpha by the rat isolated aorta and ram seminal vesicle microsomes.

Authors:  H Bult; A G Herman; V J Van de Velde
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

3.  Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.

Authors:  K S Hilliker; R A Roth
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

4.  Thromboxane mediation of cardiopulmonary effects of embolism.

Authors:  T Utsonomiya; M M Krausz; L Levine; D Shepro; H B Hechtman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

5.  Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat.

Authors:  S E Belo; J Talesnik
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

6.  Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.

Authors:  P O Hagen; Z G Wang; E M Mikat; D B Hackel
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.